mochi pricing semaglutide price vs Ro: Evidence, Cost & Differences Mochi Health Weight Loss Review – Mochi vs Remedy Meds: GLP-1

doi:10.1016/j.neuropharm.2018.01.013 184

The NICE clinical guideline on the identification, assessment and management of obesity recognises GLP-1 receptor agonists, including semaglutide, as clinically appropriate interventions for adults who meet the relevant eligibility criteria, and emphasises that clinical outcomes are achieved when treatment is delivered as intended including strict adherence to administration protocols such as the fasted dosing requirement

The compounded semaglutide guide covers this transition process in detail

10.2337/diacare.22.7.1217

Continued surges in GLP-1 agonist prescriptions are expected, so clinicians that provide sedation/anaesthesia services must understand and account for the unique anaesthetic risks for these patients